Positions

17/07/2010 ¦ Positions
CEEREAL position related to the conditions of use of health claims related to beta-glucans

CEEREAL would like to take this opportunity to comment on the current discussions regarding the conditions of use of the health claims related to beta-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 757, 801, 1465, 2934) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. We appreciate very much that the EFSA Panel on Dietetic Products, Nutrition and Allergies concludes that the food constituent, beta-glucan, which is the subject of the health claims is sufficiently characterised. Also that a cause and effect relationship has been established between the consumption of beta-glucan and the reduction of blood cholesterol concentrations.

In those member states where a similar claim is already approved, the specific requirement is set which states a minimum on 0.75g of beta glucan per serving. We therefore believe that products carrying the claim should:

• contain at least 0.75 g beta-glucan soluble fibre per serving, or in an amount that is customarily consumed in a day that makes a reasonable contribution to a healthy diet
• state what constitutes a serving and  the amount of beta-glucan soluble fibre provided in each serving, expressed by weight; and the proportion (i.e. ‘quarter’, ‘third’, ‘half’ etc) it contributes to a 3g suggested daily intake in each serving, e.g.

‘One serving provides 0.75g of beta glucan soluble fibre from oats, which is one quarter of 3g, the suggested daily intake’.

07/06/2010 ¦ Positions
CEEREAL Statement on Sugars

Read the CEEREAL Statement on Sugars.

07/06/2010 ¦ Positions
CEEREAL Statement on Salt

Read the CEEREAL Statement on Salt.

07/06/2010 ¦ Positions
CEEREAL Statement on Vitamin and Mineral Fortification

Read the CEEREAL Statement on Vitamin and Mineral Fortification.

07/06/2010 ¦ Positions
CEEREAL Statement on Fat

Read the CEEREAL Statement on Fat.